Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nephrotic Syndrome, Minimal Change”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 0 results

Post-approval studies (Phase 4)Study completedNCT01763580
What this trial is testing

Evaluate the Effect of Tacrolimus and Corticosteroid Combination Therapy in Patients With Minimal Change Nephrotic Syndrome

Who this might be right for
MCNSMinimal Change Nephrotic Syndrome (MCNS)
Astellas Pharma Korea, Inc. 144
Testing effectiveness (Phase 2)Study completedNCT02592798
What this trial is testing

Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Adults and Children 6 Years and Older With Excessive Loss of Protein in the Urine Due to Either Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD)

Who this might be right for
Nephrotic SyndromeFocal Segmental GlomerulosclerosisMinimal Change Disease
Bristol-Myers Squibb 36
Not applicableStudy completedNCT04075656
What this trial is testing

UrApp for Childhood Nephrotic Syndrome Management (Incident Cohort)

Who this might be right for
Idiopathic Nephrotic Syndrome
Emory University 58
Testing effectiveness (Phase 2)Looking for participantsNCT07614477
What this trial is testing

Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of EVER001 in Participants With Selected Proteinuric Glomerular Diseases

Who this might be right for
Minimal Change Disease (MCD)IgA Nephropathy (IgAN)Focal Segmental Glomerulosclerosis (FSGS)
Everest Medicines (China) Co.,Ltd. 45
Testing effectiveness (Phase 2)WithdrawnNCT02997150
What this trial is testing

Treatment of Steroid Dependent Idiopathic Nephrotic Syndrome in Children With Low Doses of Interleukin 2: a Pilot Study

Who this might be right for
Nephrotic Syndrome Steroid-DependentInterleukin 2
University Hospital, Limoges
Early research (Phase 1)UnknownNCT02382874
What this trial is testing

Allogenic AD-MSC Transplantation in Idiopathic Nephrotic Syndrome (Focal Segmental Glomerulosclerosis)

Who this might be right for
Focal Segmental Glomerulosclerosis
Royan Institute 5
Large-scale testing (Phase 3)Study completedNCT01084980
What this trial is testing

Therapeutic Effect of Tacrolimus in Combination With Low Dose Corticosteroid in Adult Patient With Minimal Change Nephritic Syndrome

Who this might be right for
Minimal Change Disease
Seoul National University Hospital 20
Post-approval studies (Phase 4)UnknownNCT01346007
What this trial is testing

Study of 7-valent Pneumococcal Conjugate Vaccine in Children With Idiopathic Nephrotic Syndrome

Who this might be right for
Idiopathic Nephrotic Syndrome
National and Kapodistrian University of Athens 50
Not applicableLooking for participantsNCT01605266
What this trial is testing

INSIGHT (Insight Into Nephrotic Syndrome)

Who this might be right for
Nephrotic Syndrome
The Hospital for Sick Children 1,000
Not applicableLooking for participantsNCT04924712
What this trial is testing

INS, B Cells and Microbiota

Who this might be right for
MicrobiotaB-lymphocytesGlomerulosclerosis+1 more
Nantes University Hospital 30